Zevra Therapeutics (ZVRA) Gross Margin (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Gross Margin of 96.16% for Q2 2026, up 43.95 percentage points from 52.20% a year earlier and up 1.40 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Gross Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Zevra Therapeutics was 95.46%, up 23.51 percentage points year-over-year; for FY2025, it was 84.52%, up 15.94 percentage points from FY2024.
- Annual Gross Margin shows a four-year change of -8.29 percentage points (FY2021 to FY2025).
- In prior years, Zevra Therapeutics' Gross Margin was 68.59% in FY2024 (-23.50 pp), 92.09% in FY2023 (-5.73 pp), 97.82% in FY2022 (+5.00 pp) and 92.81% in FY2021.
- The Q2 2026 figure stands as the highest quarterly Gross Margin since Q4 2022.
- On a year-over-year basis, Gross Margin has increased in each of the last five quarters, with an average year-over-year change of +10.20 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q3 2025, with a gain of 57.50 percentage points; the weakest was Q2 2024, with a drop of 72.32 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 94.76% (Q1 2026), 95.55% (Q4 2025) and 95.26% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 85.33% |
| 10 | Zevra Therapeutics | 672.94 Mn | -139.77 Mn | 38.18 Mn | 96.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.16% |
| Mar 31, 2026 | 94.76% |
| Dec 31, 2025 | 95.55% |
| Sep 30, 2025 | 95.26% |
| Jun 30, 2025 | 52.20% |
| Mar 31, 2025 | 93.41% |
| Dec 31, 2024 | 88.63% |
| Sep 30, 2024 | 37.76% |
| Jun 30, 2024 | 19.69% |
| Mar 31, 2024 | 94.89% |
| Dec 31, 2023 | 90.50% |
| Sep 30, 2023 | 95.03% |
| Jun 30, 2023 | 92.01% |
| Mar 31, 2023 | 96.06% |
| Dec 31, 2022 | 98.91% |
| Sep 30, 2022 | 95.09% |
| Jun 30, 2022 | 96.08% |
| Mar 31, 2022 | 99.80% |
| Dec 31, 2021 | 97.71% |
| Sep 30, 2021 | 100.00% |
API Access
Zevra Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();